nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Clinical Nomogram for Predicting Overall Survival in Patients With T1/T2 Penile Squamous Cell Carcinoma
|
Qian, Shian |
|
|
22 |
5 |
p. |
artikel |
2 |
A Comparison of ChatGPT and Human Questionnaire Evaluations of the Urological Cancer Videos Most Watched on YouTube
|
Demirci, Aykut |
|
|
22 |
5 |
p. |
artikel |
3 |
A Real World Observational Study Characterizing Patients With Advanced Prostate Cancer Treated With or Without Androgen Receptor-Pathway-Inhibitor Therapies in Alberta, Canada
|
O'Sullivan, Dylan E. |
|
|
22 |
5 |
p. |
artikel |
4 |
Assessing the Heterogeneity of Response of [68Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate Cancer
|
Dell'Oro, Mikaela |
|
|
22 |
5 |
p. |
artikel |
5 |
A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer
|
Hekman, Lauren |
|
|
22 |
5 |
p. |
artikel |
6 |
Bi-Parameter MRI Could Quantitatively Assess the Zonal Heterogeneity of Prostate Cancer
|
Han, Ye |
|
|
22 |
5 |
p. |
artikel |
7 |
Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism
|
Mobaraki, Sajedeh |
|
|
22 |
5 |
p. |
artikel |
8 |
Can Bladder MRI Improve the Follow-Up of Non–Muscle-Invasive Bladder Cancer by Detecting Endoscopic Invisible Recurrence?
|
Dewulf, Karel |
|
|
22 |
5 |
p. |
artikel |
9 |
Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors
|
Suzuki, Kotaro |
|
|
22 |
5 |
p. |
artikel |
10 |
Combination Chemotherapy With TS-1 and Cisplatin for Urinary Adenocarcinoma: A Retrospective Case Series
|
Omiya, Akifumi |
|
|
22 |
5 |
p. |
artikel |
11 |
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry
|
Cortes, Julian A. |
|
|
22 |
5 |
p. |
artikel |
12 |
Comment on “An Update on Focal Therapy for Prostate Cancer”
|
Sudhakaran, Gokul |
|
|
22 |
5 |
p. |
artikel |
13 |
Comment on “Evaluating Biomarkers for Testosterone Replacement Efficacy in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency”
|
Sudhakaran, Gokul |
|
|
22 |
5 |
p. |
artikel |
14 |
Comment on Real-world Efficacy and Toxicity Analysis of Abiraterone Acetate versus Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer in Asian Patients
|
Sudhakaran, Gokul |
|
|
22 |
5 |
p. |
artikel |
15 |
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
|
Del Re, Marzia |
|
|
22 |
5 |
p. |
artikel |
16 |
Disparities in Penile Cancer Incidence, Mortality, and Place of Death Trends From 1999 to 2020
|
Mansur, Arian |
|
|
22 |
5 |
p. |
artikel |
17 |
Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma
|
Jeyaraj, Gnanaprakash |
|
|
22 |
5 |
p. |
artikel |
18 |
Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study
|
Bellmunt, Joaquim |
|
|
22 |
5 |
p. |
artikel |
19 |
Effect of Bacillus Calmette–Guerin Exposure on Prostate Cancer Detection Using Magnetic Resonance Imaging: A Cohort Study
|
Rodríguez Cabello, Miguel Angel |
|
|
22 |
5 |
p. |
artikel |
20 |
Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas
|
Moinard-Butot, F. |
|
|
22 |
5 |
p. |
artikel |
21 |
Final Analysis of a Noninterventional Study on Cabozantinib in Patients With Advanced Renal Cell Carcinoma After Prior Checkpoint Inhibitor Therapy of the German Interdisciplinary Working Group on Renal Tumors (IAG-N)
|
Viktor, Grünwald |
|
|
22 |
5 |
p. |
artikel |
22 |
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives
|
Turco, Fabio |
|
|
22 |
5 |
p. |
artikel |
23 |
Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors
|
Silberg, Matteo |
|
|
22 |
5 |
p. |
artikel |
24 |
Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Mamede, Isadora |
|
|
22 |
5 |
p. |
artikel |
25 |
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
|
Skelton IV, William Paul |
|
|
22 |
5 |
p. |
artikel |
26 |
Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus
|
Ali, Soham |
|
|
22 |
5 |
p. |
artikel |
27 |
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients
|
Wenzel, Mike |
|
|
22 |
5 |
p. |
artikel |
28 |
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney
|
Giudice, Giulia Claire |
|
|
22 |
5 |
p. |
artikel |
29 |
Metastatic Tropism in Urothelial Carcinoma With Variant Histology: A Comprehensive NCDB Analysis
|
Drouaud, Arthur |
|
|
22 |
5 |
p. |
artikel |
30 |
Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates
|
de Angelis, Mario |
|
|
22 |
5 |
p. |
artikel |
31 |
New Insights of Target Therapy: Effects of Tyrosine Kinase Inhibitors on Male Gonadal Function: A Systematic Review
|
Marino, Marta |
|
|
22 |
5 |
p. |
artikel |
32 |
Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors
|
Tural, Deniz |
|
|
22 |
5 |
p. |
artikel |
33 |
Organ-Specific Tumor Response to Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study
|
Minato, Akinori |
|
|
22 |
5 |
p. |
artikel |
34 |
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study
|
Fotia, Giuseppe |
|
|
22 |
5 |
p. |
artikel |
35 |
Outcomes of Intraoperative Frozen Section Examination of Surgical Resection Margins of the Penis in Penile Cancer
|
Pang, Karl H. |
|
|
22 |
5 |
p. |
artikel |
36 |
Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN)
|
Gunenc, Damla |
|
|
22 |
5 |
p. |
artikel |
37 |
Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance
|
Yang, Tao |
|
|
22 |
5 |
p. |
artikel |
38 |
Predicting Treatment Effects from Surrogate Endpoints in Historical Trials in First-Line Metastatic Castration-Resistant Prostate Cancer
|
Samjoo, Imtiaz A. |
|
|
22 |
5 |
p. |
artikel |
39 |
Prognostic Model and Immune Response of Clear Cell Renal Cell Carcinoma Based on Co-Expression Genes Signature
|
Yang, Dongsheng |
|
|
22 |
5 |
p. |
artikel |
40 |
Prognostic Nutritional Index (PNI) as Independent Predictor of Poor Survival in Prostate Cancer: A Systematic Review and Meta-Analysis
|
Tobing, Edwin |
|
|
22 |
5 |
p. |
artikel |
41 |
Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy
|
Salari, Abolfazl |
|
|
22 |
5 |
p. |
artikel |
42 |
PSA Levels and Mortality in Prostate Cancer Patients
|
Jehle, Dietrich von Kuenssberg |
|
|
22 |
5 |
p. |
artikel |
43 |
Rates of Systemic Therapy for Metastatic Bladder Cancer Are Lower in Unmarried Males and Females
|
Vitucci, Kira |
|
|
22 |
5 |
p. |
artikel |
44 |
Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study Results
|
Nathan, Paul |
|
|
22 |
5 |
p. |
artikel |
45 |
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER Registries
|
Cano Garcia, Cristina |
|
|
22 |
5 |
p. |
artikel |
46 |
Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases
|
Di Bello, Francesco |
|
|
22 |
5 |
p. |
artikel |
47 |
Surviving the Storm: Challenges of Bladder Cancer Care During the COVID-19 Pandemic
|
Vinícius Suartz, Caio |
|
|
22 |
5 |
p. |
artikel |
48 |
The Clinicopathological Characteristics and Prognosis of 55 Patients With TFE3-Rearranged Renal Cell Carcinomas
|
Bai, Yin-Miao |
|
|
22 |
5 |
p. |
artikel |
49 |
The Development and Feasibility of a Novel Electronic Patient-Reported Outcome Measures (Eproms) Questionnaire in patients with penile cancer
|
Adegboye, Oluwatobi |
|
|
22 |
5 |
p. |
artikel |
50 |
The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population
|
Souza, Vinicius Carrera |
|
|
22 |
5 |
p. |
artikel |
51 |
The Incidence of Extreme Serum Prostate Specific Antigen Levels During the COVID-19 Pandemic
|
Hird, Amanda E. |
|
|
22 |
5 |
p. |
artikel |
52 |
“The Prognostic Value of Human Papillomavirus Status in Penile Cancer: Outcomes From a Norwegian Cohort Study.”
|
Jeyaraj, Gnanaprakash |
|
|
22 |
5 |
p. |
artikel |
53 |
The Prognostic Value of Human Papillomavirus Status in Penile Cancer: Outcomes From a Norwegian Cohort Study
|
Nordanger, Ida M. |
|
|
22 |
5 |
p. |
artikel |
54 |
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate
|
Meyer, Haley |
|
|
22 |
5 |
p. |
artikel |